18
Participants
Start Date
April 30, 2012
Primary Completion Date
June 30, 2012
Study Completion Date
June 30, 2012
Oxycodone
1X40 mg PF-00345439 formulation A capsule with water and under fed condition
Oxycodone
1X40 mg PF-00345439 formulation B capsule with water and under fed condition
Oxycodone
1X40 mg PF-00345439 formulation C capsule with water and under fed condition
Oxycodone
1X40 mg PF-00345439 formulation D capsule with water and under fed condition
Oxycodone
40 mg oxycodone oral solution (5 mg/5 ml) with water and under fed condition
Pfizer Investigational Site, Singapore
Lead Sponsor
Pain Therapeutics
INDUSTRY